What is the long-term trend for BioMarin Pharmaceuticals's amortization of financing costs and discounts?

Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's amortization of financing costs and discounts has grown at a -10.8% compound annual growth rate (CAGR), from $4.15M to $2.62M.

BioMarin Pharmaceuticals BMRN Amortization Of Financing Costs And Discounts

Amortization Of Financing Costs And Discounts at other companies

Equity ResidentialEQR

$2.15M0.0%

Allison Transmission HoldingsALSN

$7M—

TeraWulfWULF

$13.22M+2,079%

Omega Healthcare InvestorsOHI

$3.4M+147%

Claros Mortgage TrustCMTG

$6.49M+12.5%

Digital RealtyDLR

$9.26M+116%

Other financials

Income statement

See full

Revenue$766.2M+2.8%

Gross profit$571.2M-3.8%

Operating income$129.6M-42.1%

Net income$105.5M-43.2%

EPS (diluted)$0.54-43.2%

Balance sheet

See full

Cash & equivalents$3.1B+193%

Total debt$1.4B+138%

Total equity$6.2B+7.2%

Total assets$8.6B+20.2%

Cash flow

See full

Operating cash flow$220.7M+26.5%

CapEx$20.9M+24.8%

Free cash flow$199.7M+26.7%

Valuation

See full

Market cap$10.57B-19.4%

Enterprise value$8.93B-29.3%

P/E21.1×-22.7×

P/S3.3×-1.2×

Profitability

See full

Gross margin76.5%-2.9pp

Operating margin19.9%+7.2pp

Net margin16.8%+5.1pp

FCF margin23.7%+2.5pp

Returns & leverage

See full

Return on equity9.1%+2.8pp

Debt / equity0.2×+0.1×

Current ratio5.8×+0.3×

Where this comes from

Reported directly by BioMarin Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioMarin Pharmaceuticals's amortization of financing costs and discounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioMarin Pharmaceuticals's amortization of financing costs and discounts?: BioMarin Pharmaceuticals (BMRN) reported amortization of financing costs and discounts of $6.09M in Q1 2026.
How has BioMarin Pharmaceuticals's amortization of financing costs and discounts changed year-over-year?: BioMarin Pharmaceuticals's amortization of financing costs and discounts increased by 822.1% year-over-year, from $660K to $6.09M.
What is the long-term trend for BioMarin Pharmaceuticals's amortization of financing costs and discounts?: Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's amortization of financing costs and discounts has grown at a -10.8% compound annual growth rate (CAGR), from $4.15M to $2.62M.